Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Making BsUFA III Regulatory Science Grants Available Early
Mar 07 2022
•
By
Derrick Gingery
The biosimilar regulatory science research pilot program is intended to resemble the FDA program already created for generic drugs. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics